When did Idexx Laboratories report Q4 2024 earnings?

Idexx Laboratories (IDXX) reported Q4 2024 earnings on February 3, 2025 before market open.

What were Idexx Laboratories's Q4 2024 revenue and EPS?

Idexx Laboratories reported revenue of $954.3M and diluted EPS of $2.62 for Q4 2024.

Did Idexx Laboratories beat estimates in Q4 2024?

Revenue beat the consensus estimate of $935.1M by $19.1M. EPS beat the consensus estimate of $2.39 by $0.23.

Where can I find Idexx Laboratories's Q4 2024 SEC filings?

You can read the 10-K periodic report (0000874716-25-000037) directly on SEC EDGAR. The filing index links above go to sec.gov.

Idexx Laboratories IDXX Q4 2024 Annual earnings

Reported February 3, 2025 · Before market open

Revenue$954.3MBeat by $19.1M Diluted EPS$2.62Beat by $0.23

Revenue estimate$935.1M

EPS estimate$2.39

Next report

Aug 4, 2026 (In 3 weeks)

Revenue estimate$1.2B

EPS estimate$3.95

Financials

Q4 2024

Income statement

See full

Revenue$954.3M+5.8%

Gross profit$570.7M+8.5%

Operating income$261.7M+6.7%

Net income$216.1M+11.1%

EPS (diluted)$2.62+13.4%

Balance sheet

See full

Cash & equivalents$288.3M-36.5%

Total debt$736.9M-9.8%

Total equity$1.6B+7.5%

Total assets$3.3B+1.0%

Cash flow

See full

Operating cash flow$262.0M+4.9%

CapEx$29.3M-10.1%

Free cash flow$232.8M+7.1%

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$33.85B-26.6%

Enterprise value$34.3B-26.2%

P/E38.1×-16.4×

P/S8.7×-3.9×

Profitability

See full

Gross margin61%+1.2pp

Operating margin29%-1.0pp

Net margin22.8%-0.3pp

FCF margin20.7%-0.4pp

Returns & leverage

See full

Return on equity57.7%-23.1pp

Debt / equity0.5×-0.1×

Current ratio1.3×-0.3×

Segments

By geography

See full

United States$604.0M—

Germany$43.4M—

Canada$38.3M—

United Kingdom$33.7M—

France$27.7M—

By product

See full

IDEXX VetLab consumables$331.8M+11.6%

Reference laboratory diagnostic and consulting services$316.0M+3.6%

Rapid assay products$77.4M-0.2%

Recurring revenue$62.9M+15.3%

CAG Diagnostics capital - instruments$33.0M-13.5%

By segment

See full

CAG$870.5M+6.0%

Water segment revenue$45.2M+8.1%

LPD$34.6M+5.4%

Versus estimates

Revenue

Q1 2026$1.1BBeat by $22.3M Q4 2025$1.1BBeat by $17.9M Q3 2025$1.1BBeat by $32.0M Q2 2025$1.1BBeat by $47.1M Q1 2025$998.4MBeat by $1.3M

Q4 2024$954.3MBeat by $19.1M

Diluted EPS

Q1 2026$3.47Beat by $0.06 Q4 2025$3.08Beat by $0.15 Q3 2025$3.40Beat by $0.26 Q2 2025$3.63Beat by $0.35 Q1 2025$2.96Beat by $0.11

Q4 2024$2.62Beat by $0.23

Ask the moment Idexx Laboratories reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Idexx Laboratories report Q4 2024 earnings?: Idexx Laboratories (IDXX) reported Q4 2024 earnings on February 3, 2025 before market open.
What were Idexx Laboratories's Q4 2024 revenue and EPS?: Idexx Laboratories reported revenue of $954.3M and diluted EPS of $2.62 for Q4 2024.
Did Idexx Laboratories beat estimates in Q4 2024?: Revenue beat the consensus estimate of $935.1M by $19.1M. EPS beat the consensus estimate of $2.39 by $0.23.
Where can I find Idexx Laboratories's Q4 2024 SEC filings?: You can read the 10-K periodic report (0000874716-25-000037) directly on SEC EDGAR. The filing index links above go to sec.gov.